Evidence map›Paper›PMID 42166039›Full record

ReviewPediatric nephrology (Berlin, Germany)2026

A dual-organ genetic interplay between sensorineural hearing loss and kidney disease: an update for clinicians.

Jayakumar Swetha, Mani Nirmala Meenu, Irisappan Ganesh, Mathuravalli Krishnamoorthy, Sambandam Ravikumar, Kumar Rangarajalu

Abstract readReview
PubMed Publisher
In one paragraph

Review in Pediatric nephrology (Berlin, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jayakumar Swetha *Department of Biochemistry, Aarupadai Veedu Medical College & Hospital, Vinayaka Mission's Research Foundation (DU), Puducherry, India.
Mani Nirmala Meenu *Department of Medical Biotechnology, Aarupadai Veedu Medical College and Hospital, Vinayaka Mission's Research Foundation (DU), Puducherry, India.
Irisappan GaneshDepartment of Medical Biotechnology, Aarupadai Veedu Medical College and Hospital, Vinayaka Mission's Research Foundation (DU), Puducherry, India.
Mathuravalli KrishnamoorthyDepartment of Genetics, Post Graduate Institute of Basic Medical Sciences, University of Madras (Taramani Campus), Chennai, Tamil Nadu, India.
Sambandam RavikumarDepartment of Medical Biotechnology, Aarupadai Veedu Medical College and Hospital, Vinayaka Mission's Research Foundation (DU), Puducherry, India. ravikumar.sambandam@avmc.edu.in.ORCID http://orcid.org/0000-0001-7351-0421
Kumar RangarajaluDepartment of Biochemistry, Aarupadai Veedu Medical College & Hospital, Vinayaka Mission's Research Foundation (DU), Puducherry, India. kumar.rangarajalu@avmc.edu.in.ORCID http://orcid.org/0000-0002-9848-030X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hearing loss (HL) and chronic kidney disease (CKD) are conditions with high prevalence worldwide. Patients with oto-renal disorders are reported to have both syndromic forms of HL and kidney dysfunction due to common molecular signaling pathways. The major shared genetic factors, common developmental pathways, and physiological mechanisms adversely affect the auditory and kidney systems. This review consolidates the common morphogenic origins of the kidney and the cochlea, which focus on the major shared genes, networks, and oto-renal disorders that affect the cilia, collagen networks, and transport channels in both systems. This article shines a spotlight on mechanisms and pathophysiology of the major congenital disorders causing HL and kidney diseases. In addition to this, other risk factors including hemodialysis and certain drugs increase the risk of HL in patients with CKD. This review can help clinicians navigate options for differential diagnosis of oto-renal disorders. An interdisciplinary approach across nephrologists, audiologists, pediatricians, and geneticists can pave the way for effective screening, diagnosis, and treatment interventions. This also underscores the importance of future research on the ear-kidney axis to understand molecular signaling, biomarker discovery, and clinical management.

Indexed as

Alport syndromeBartter syndromeChronic kidney disease (CKD)Oto-renal disordersSyndromic hearing loss (SHL)

Identifiers

PMID42166039

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.